小腹主动脉瘤患者心血管事件风险显著且未被充分管理
研究基于英国腹主动脉瘤生长研究(UKAGS)384例小腹主动脉瘤(AAA,直径<55 mm)男性及142例本地队列患者,评估其心血管(CV)风险特征。结果显示多数患者吸烟、高血压和高胆固醇血症患病率高,进入AAA监测后未更易接受CV药物,且全部本地患者Framingham、JBS-2和ASSIGN评分均属高风险,1年内收缩压无变化而胆固醇升高。结论认为小AAA患者CV风险显著且未被充分处理,需设计针对性CV风险降低方案。
要点
- 小AAA患者心血管风险高,但监测期间CV药物使用未增加。
- 全部本地患者Framingham、JBS-2和ASSIGN评分均属高风险。
- 1年内收缩压无变化,胆固醇从4.0 mmol升至4.2 mmol。
核心结论
- 小AAA患者心血管事件风险显著,且当前未被充分处理。
研究设计与样本
- 评估384例UKAGS小AAA(<55 mm)男性及142例本地小AAA患者血压和血脂谱的前瞻性队列。
主要发现
- UKAGS人群54%现吸烟、30%曾吸烟,58%高血压,54%高胆固醇血症。
- 本地组54%现吸烟、40%曾吸烟,94%高血压。
- 两组进入AAA监测后接受CV药物的可能性未增加。
- 本地患者Framingham评分均值21.8%(95%CI 20.0-23.6),JBS-2 16.3%(14.7-17.9),ASSIGN 25.2%(22.7-27.7)。
- 1年收缩压无变化(140.9 mmHg vs 142.5 mmHg,p=.435),胆固醇升高(4.0 mmol-4.2 mmol,p<.0001)。
临床怎么用
- 对进入AAA监测的小AAA患者应主动评估和管理心血管风险。
- 需设计并实施针对该人群的CV风险降低方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with abdominal aortic aneurysm (AAA) are at significant risk of cardiovascular (CV) events. Recent implementation of AAA-screening means thousands of patients are now diagnosed with small-AAA; however, CV risk factors are not always addressed. This study aimed at assessing and quantifying the CV characteristics of patients with small AAA following the introduction of screening programmes. METHODS: CV profiles of 384 men with a small AAA (<55 mm diameter) were assessed through the United Kingdom Aneurysm Growth Study (UKAGS), a nationwide prospective cohort study of men with small AAA. A prospective local cohort of an additional 142 patients with small AAA with available blood pressure (BP) and lipid profiles was also included and followed-up for 1 year. RESULTS: In the UKAGS population, 54% were current and 30% ex-smokers; 58% were hypertensive and 54% hypercholesterolaemic. In the local group, 54% were current and 40% were ex-smokers, and 94% were hypertensive. Patients were not more likely to receive CV medication after entering AAA surveillance in either group. All local patients were clustered "high-risk" for future CV events based on the Framingham score (mean 21.8%, 95% CI 20.0-23.6), JBS-2 (16.3%, 14.7-17.9) and ASSIGN (25.2%, 22.7-27.7). No change was seen in systolic BP levels between baseline and 1 year (140.9 mmHg vs. 142.5 mmHg, p=.435). A rise was seen in cholesterol (4.0 mmol-4.2 mmol, p<.0001) values at 1 year. CONCLUSIONS: This study suggests that patients with small AAA are at significant risk for developing CV events and this is not currently addressed, which is evident by the "high-risk" CV risk profiles of these patients despite being in AAA surveillance. Design and implementation of a CV risk reduction programme tailored for this population is necessary.
引用
- Bath MF, Saratzis A, Saedon M, et al. Patients with Small Abdominal Aortic Aneurysm are at Significant Risk of Cardiovascular Events and this Risk is not Addressed Sufficiently. Eur J Vasc Endovasc Surg. 2016. PMID: 27884711. doi:10.1016/j.ejvs.2016.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。